Terms: = Uterine cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG
340 results:
1. muc1 promotes cervical squamous cell carcinoma through ERK phosphorylation-mediated regulation of ITGA2/ITGA3.
Zhao A; Pan Y; Gao Y; Zhi Z; Lu H; Dong B; Zhang X; Wu M; Zhu F; Zhou S; Ma S
BMC Cancer; 2024 May; 24(1):559. PubMed ID: 38702644
[TBL] [Abstract] [Full Text] [Related]
2. Anaplastic large cell lymphoma presenting as a mass in the uterine cervix: a case report.
Mingola P; Alshomrani A; Greiner T
J Hematop; 2024 Mar; 17(1):23-26. PubMed ID: 38376721
[TBL] [Abstract] [Full Text] [Related]
3. Immune checkpoint inhibitors with chemotherapy for primary advanced mismatch repair-deficient endometrial cancer: A cost-effectiveness analysis.
Kim J; Lim J; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim DY
Gynecol Oncol; 2023 Dec; 179():106-114. PubMed ID: 37976756
[TBL] [Abstract] [Full Text] [Related]
4. Validation of an on-chip p16
Hashimoto K; Kumagai T; Nomura K; Miyagawa Y; Tago S; Takasaki K; Takahashi Y; Nishida H; Ichinose T; Hirano M; Hiraike H; Wada-Hiraike O; Sasajima Y; Kim SH; Nagasaka K
Sci Rep; 2023 Oct; 13(1):17052. PubMed ID: 37816765
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Value Analysis of Serum TK1, SCC-Ag, and MUC-1 in the Diagnosis and Prognosis Evaluation of Cervical cancer.
Zhang M; Xin L; Cheng B; Yan B; Zhen J; Yang C; Ma L; Hou Q
Altern Ther Health Med; 2023 Nov; 29(8):788-792. PubMed ID: 37708549
[TBL] [Abstract] [Full Text] [Related]
6. In what ways does user experience design improve printed educational materials?
Kealey MR; Urakami J; Henderson K; Chignell M; Straus SE
Appl Ergon; 2023 Nov; 113():104081. PubMed ID: 37393832
[TBL] [Abstract] [Full Text] [Related]
7. Undifferentiated component of dedifferentiated endometrial carcinoma presenting as a "small round cell" malignancy in a mediastinal lymph node, mimicking small cell carcinoma.
Balikani L; Policarpio-Nicolas MLC
Diagn Cytopathol; 2023 Aug; 51(8):519-524. PubMed ID: 37318779
[TBL] [Abstract] [Full Text] [Related]
8. uterine choriocarcinoma coexistence with endometroid adenocacinoma: a case report and literature review.
Bai L; Chen Y; Han L; Zheng A; Mo X
BMC Womens Health; 2023 May; 23(1):252. PubMed ID: 37165420
[TBL] [Abstract] [Full Text] [Related]
9. CREB fusion-associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype.
Trecourt A; Macagno N; Ngo C; Philip CA; Lopez J; Ferreira J; Alves-Vale C; Ray-Coquard I; Genestie C; Agaimy A; Devouassoux-Shisheboran M
Virchows Arch; 2023 Jun; 482(6):967-974. PubMed ID: 37097347
[TBL] [Abstract] [Full Text] [Related]
10. Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG oncology/GOG study.
Benbrook DM; Deng W; Gold MA; Rai R; Conrad R; van der Wel H; Husain S; Moore K; Spirtos N; Jackson AL; Zakhour M; Mathews CA; West CM
Gynecol Oncol; 2023 Apr; 171():67-75. PubMed ID: 36827840
[TBL] [Abstract] [Full Text] [Related]
11. Endometrial carcinosarcoma.
Bogani G; Ray-Coquard I; Concin N; Ngoi NYL; Morice P; Caruso G; Enomoto T; Takehara K; Denys H; Lorusso D; Coleman R; Vaughan MM; Takano M; Provencher DM; Sagae S; Wimberger P; Póka R; Segev Y; Kim SI; Kim JW; Candido Dos Reis FJ; Ramirez PT; Mariani A; Leitao M; Makker V; Abu-Rustum NR; Vergote I; Zannoni G; Tan D; McCormack M; Paolini B; Bini M; Raspagliesi F; Benedetti Panici P; Di Donato V; Muzii L; Colombo N; Pignata S; Scambia G; Monk BJ
Int J Gynecol Cancer; 2023 Feb; 33(2):147-174. PubMed ID: 36585027
[TBL] [Abstract] [Full Text] [Related]
12. The role of immunotherapy in advanced and recurrent MMR deficient and proficient endometrial carcinoma.
Di Dio C; Bogani G; Di Donato V; Cuccu I; Muzii L; Musacchio L; Scambia G; Lorusso D
Gynecol Oncol; 2023 Feb; 169():27-33. PubMed ID: 36493574
[TBL] [Abstract] [Full Text] [Related]
13. Advanced and recurrent endometrial cancer: State of the art and future perspectives.
Tronconi F; Nero C; Giudice E; Salutari V; Musacchio L; Ricci C; Carbone MV; Ghizzoni V; Perri MT; Camarda F; Gentile M; Berardi R; Scambia G; Lorusso D
Crit Rev Oncol Hematol; 2022 Dec; 180():103851. PubMed ID: 36257537
[TBL] [Abstract] [Full Text] [Related]
14. Investigating the relationship between the cervical mucoprotein levels and cervical intraepithelial neoplasia.
Kulaksiz D; Bayoglu Tekin Y; Deger O; Baki Erin K
Minerva Obstet Gynecol; 2023 Dec; 75(6):559-564. PubMed ID: 35785924
[TBL] [Abstract] [Full Text] [Related]
15. Atypical presentation of a rare gestational trophoblastic neoplasm: A case report.
Aamir FB; Raza Raja MH; Ahmad Zaidi SM; Noorali AA; Pervez MB; Fatimi SH
J Pak Med Assoc; 2022 Jun; 72(6):1260-1262. PubMed ID: 35751357
[TBL] [Abstract] [Full Text] [Related]
16. The study of clinicopathologic features of cervical squamous carcinoma with invasive micropapillary like pattern and phenotype.
Wang H; Yang K; Li Q; Su W; Liu X; Feng K; Song H; Li S; Jiang H
Histol Histopathol; 2022 Sep; 37(9):853-861. PubMed ID: 35510512
[TBL] [Abstract] [Full Text] [Related]
17. Endometrial giant cell carcinoma: new insights from a morphological, immunohistochemical, and molecular analysis of three cases.
Arciuolo D; Travaglino A; Raffone A; Santoro A; Russo G; Minucci A; Inzani F; Mollo A; Pedone Anchora L; Fanfani F; Insabato L; Zannoni GF
Virchows Arch; 2022 Aug; 481(2):321-326. PubMed ID: 35305145
[TBL] [Abstract] [Full Text] [Related]
18. Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids.
Middelkoop MA; de Lange ME; Clark TJ; Mol BWJ; Bet PM; Huirne JAF; Hehenkamp WJK
Hum Reprod; 2022 May; 37(5):884-894. PubMed ID: 35143669
[TBL] [Abstract] [Full Text] [Related]
19. METASTATIC CHORIOCARCINOMA PRESENTING AS RENAL COLIC AND SKIN LESION - CASE REPORT.
Pietrus M; Czekaj A; Dziadkowiak D; Ratajczyk K; Trzciniecki M; Kowal P; Mytsyk Y
Wiad Lek; 2021; 74(7):1763-1766. PubMed ID: 34459784
[TBL] [Abstract] [Full Text] [Related]
20. Management of symptomatic uterine fibroids after ulipristal acetate suspension and identification of high risk patients for surgery at 6-months of follow-up.
Nicolás I; Martínez-Zamora MÁ; Gracia M; Carrion A; Feixas G; Bernal L; Quintas L; Rius M; Castelo-Branco C; Carmona F
Gynecol Endocrinol; 2021 Sep; 37(9):831-835. PubMed ID: 34044726
[TBL] [Abstract] [Full Text] [Related]
[Next]
